Ruth Pinter
Family · North Hollywood, CANPI 1417116732
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.6% of the total across 184 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by Forte Bio-pharma LLC at 43.0% of the total. 2025 is the largest year on record at $1,239, more than ten times the $67 reported in 2021. Among family clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 184 payments — averaging $17.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Forte Bio-pharma LLC$1K
- Collegium Pharmaceutical, Inc.$433
- Novartis$410
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$308
- Pfizer$113
- Virtus Pharmaceuticals LLC$67
- plus $455 from 15 others
What the payments were for
- Food & beverage$3,121100%
- Education$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Forte Bio-pharma LLC | 86 | $1,346 |
| Collegium Pharmaceutical, Inc. | 27 | $433 |
| Novartis | 24 | $410 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 17 | $308 |
| Pfizer | 5 | $113 |
| Virtus Pharmaceuticals LLC | 3 | $67 |
| Boston Scientific | 2 | $55 |
| AbbVie | 2 | $54 |
| Upsher-smith Laboratories LLC | 2 | $50 |
| Vertex | 2 | $44 |
| Medtronic | 2 | $40 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $36 |
| Lilly USA, LLC | 2 | $36 |
| IBSA Pharma Inc. | 1 | $24 |
| SPR Therapeutics, Inc | 1 | $22 |
| Johnson & Johnson | 1 | $21 |
| Biohaven Pharmaceuticals, Inc. | 1 | $20 |
| Amneal Pharmaceuticals LLC | 1 | $16 |
| Abbott | 1 | $13 |
| Impel Pharmaceuticals Inc. | 1 | $12 |
| Stimwave Technologies Incorporated | 1 | $12 |
How this compares
$3,133 in reported general payments places this provider in the 90th percentile of 10,634 family providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ProlateOxycodone Hcl/Acetaminophen | 17 | $59,007 |
| OxycontinOxycodone Hcl | 74 | $53,074 |
| Xtampza ErOxycodone Myristate | 55 | $47,971 |
| NucyntaTapentadol Hcl | 29 | $38,624 |
| MovantikNaloxegol Oxalate | 55 | $23,375 |
| Nurtec OdtRimegepant Sulfate | 13 | $22,412 |
| LinzessLinaclotide | 29 | $20,463 |
| Nucynta ErTapentadol Hcl | 13 | $20,042 |
| Levorphanol Tartrate | 17 | $18,624 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 637 | $18,007 |
| Aimovig AutoinjectorErenumab-Aooe | 12 | $14,588 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 317 | $14,071 |
| BelbucaBuprenorphine Hcl | 16 | $11,399 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 64 | $7,495 |
| Oxycodone Hcl | 298 | $6,941 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Xtampza Er, Nucynta, Nucynta Er, Belbuca | $433 | $118,036113 claims |
| Forte Bio-pharma LLCProlate | $1,346 | $59,00717 claims |
| PfizerNurtec Odt | $113 | $22,41213 claims |
| AbbVieLinzess | $54 | $20,46329 claims |
| Virtus Pharmaceuticals LLCLevorphanol Tartrate | $67 | $18,62417 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 10,634 family providers in California.
Other family in North Hollywood
- Lori RobertsonChino Hills$475K
- Annette ShonLos Angeles$406K
- Lisa HigginsHanford$311K
- Jennifer TougasBakersfield$302K
- Kim SchaferSacramento$288K
- Dawn MeyerSan Diego$270K
- Jennifer KangCerritos$255K
- Erin DwyerSan Diego$189K
- Phyllis CasonLos Angeles$187K
- Gabriel SchwartzSan Francisco$166K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.